Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H15ClF4N4O3 |
Molecular Weight | 482.815 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=O)C1=NC=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=C1
InChI
InChIKey=FNHKPVJBJVTLMP-UHFFFAOYSA-N
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1742
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
WHO-ATC |
L01XE21
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
329410
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
NCI_THESAURUS |
C1404
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
NCI_THESAURUS |
C129825
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
LIVERTOX |
839
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
STIVARGA (AUTHORIZED: COLORECTAL NEOPLASMS)
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
690619
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
NDF-RT |
N0000175605
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
WHO-VATC |
QL01XE21
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
478015
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000136039
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
68647
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
Regorafenib
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
755037-03-7
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
5891
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
DB08896
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
24T2A1DOYB
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
24T2A1DOYB
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
Regorafenib
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
4654
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
68646
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
SUB73090
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
C78204
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
11167602
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
1312397
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL1946170
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
m11701
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
DTXSID60226441
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
C559147
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | |||
|
N0000185504
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inhibitors [MoA] | ||
|
9026
Created by
admin on Fri Dec 15 17:21:27 UTC 2023 , Edited by admin on Fri Dec 15 17:21:27 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)
METABOLITE ACTIVE (PARENT)
METABOLITE INACTIVE (PARENT)
METABOLITE INACTIVE (PARENT)
METABOLITE INACTIVE (PARENT)
SALT/SOLVATE (PARENT)